| Harris, S.F.; Wu, P. (2024). Mtb GuaB dCBS in complex with inhibitor G1. Protein Data Bank: 9dc8. |
CMCF-BM |
PDB Deposition |
Health |
| Grainger, R.; Colussi, D.C.; Noble, M.; Junop, M.; Stathopulos, P.B. et al. (2025). Human mitochondrial calcium uniporter crystal structure (residues 74-165 resolved) with lithium. Protein Data Bank: 8urg. |
CMCF-BM |
PDB Deposition |
Health |
| Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain F39A mutant. Protein Data Bank: 9dfr. |
CMCF-BM |
PDB Deposition |
Health |
| Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain F39Q mutant. Protein Data Bank: 9dfq. |
CMCF-BM |
PDB Deposition |
Health |
| Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain K23/24Q mutant. Protein Data Bank: 9dfp. |
CMCF-BM |
PDB Deposition |
Health |
| Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain K31Q mutant. Protein Data Bank: 9dfo. |
CMCF-BM |
PDB Deposition |
Health |
| Chi, C.B.; Liang, Z.D.; Huo, B.Q.; Hu, C.X.; Sun, Q.Y. et al. (2024). Crystal structure of estZF172 as a novel biocatalyst for the efficient biosynthesis of a chiral intermediate of pregabalin. Protein Data Bank: 8j5v. |
CMCF-BM |
PDB Deposition |
Health |
| Bon, C.G.; Lee, J.; Caveney, N.A.; Strynadka, N.C.J. (2024). Structure of the monofunctional Staphylococcus aureus PBP1 in its beta-lactam (Ertapenem) inhibited form. Protein Data Bank: 8vbw. |
CMCF-BM |
PDB Deposition |
Health |
| Bon, C.G.; Lee, J.; Caveney, N.A.; Strynadka, N.C.J. (2024). Structure of the monofunctional Staphylococcus aureus PBP1 in its beta-lactam (Cephalexin) inhibited form. Protein Data Bank: 8vbv. |
CMCF-BM |
PDB Deposition |
Health |
| Bon, C.G.; Lee, J.; Caveney, N.A.; Strynadka, N.C.J. (2024). Structure of the monofunctional Staphylococcus aureus PBP1 in its apo form. Protein Data Bank: 8vbt. |
CMCF-BM |
PDB Deposition |
Health |
| Ali, M.G.H.; Wahba, H.M.; Cyr, N.; Omichinski, J.G. (2024). Crystal structure of K46 acetylated GABARAP in complex with the LIR of TP53INP2/DOR. Protein Data Bank: 8t33. |
CMCF-BM |
PDB Deposition |
Health |
| Merchant, R.R.; Chernyak, N.; Lopez, J.A.; Sharp, P.P.; Mandal, M. et al. (2026). N-Alkyl & N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors Compound 13 ((3'R)-1'-{5-amino-1-[(2S)-1,1,1-trifluorobutan-2-yl]-1H-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1H)-one). Protein Data Bank: 10qs. |
CMCF-BM |
PDB Deposition |
Materials |
| Jason Rolfe; Mehran Khodabandeh; Zaccary ALPERSTEIN; Seyed Ali Saberali; Hazem MSLATI et al. (2024). Protease inhibitors and methods of using same. Patent Number: WO2024130411A1. |
CMCF-BM |
Patent |
Health |
| Kenward, Calem Austin (2024). Structural and functional characterization of key proteins essential to the lifecycle of severe acute respiratory syndrome coronavirus 2. Supervisor: Strynadka, Natalie. University of British Columbia. http://hdl.handle.net/2429/88954. |
CMCF-BM |
Masters Thesis |
Health |
| Merchant, Rohan R.; Chernyak, Natalia; Lopez, Jovan A.; Sharp, Phillip P.; Mandal, Mihir et al. (2026). N
-Alkyl and
N
-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors. ACS Medicinal Chemistry Letters 17(3) , 744-749. 10.1021/acsmedchemlett.6c00066. [PDB: 10qs] |
CMCF-BM |
Peer-Reviewed Article |
Agriculture |